These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25978751)

  • 21. Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients.
    Marcelin AG; Grude M; Charpentier C; Bellecave P; Le Guen L; Pallier C; Raymond S; Mirand A; Bocket L; Fofana DB; Delaugerre C; Nguyen T; Montès B; Jeulin H; Mourez T; Fafi-Kremer S; Amiel C; Roussel C; Dina J; Trabaud MA; Le Guillou-Guillemette H; Vallet S; Signori-Schmuck A; Maillard A; Ferre V; Descamps D; Calvez V; Flandre P;
    J Antimicrob Chemother; 2019 May; 74(5):1368-1375. PubMed ID: 30789205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UK.
    Mbisa JL; Ledesma J; Kirwan P; Bibby DF; Manso C; Skingsley A; Murphy G; Brown A; Dunn DT; Delpech V; Geretti AM
    J Antimicrob Chemother; 2020 Nov; 75(11):3311-3318. PubMed ID: 32728703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrase Strand Transfer Inhibitor Resistance Mutations in Antiretroviral Treatment-naïve Patients in Korea: a Prospective, Observational Study.
    Kim Y; Chin BS; Kim G; Shin HS
    J Korean Med Sci; 2018 Jun; 33(25):e173. PubMed ID: 29915524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short Communication: HIV-1 Drug Resistance Mutation Analyses of Cameroon-Derived Integrase Sequences.
    Mikasi SG; Isaacs D; Ikomey GM; Shimba H; Cloete R; Jacobs GB
    AIDS Res Hum Retroviruses; 2021 Jan; 37(1):54-56. PubMed ID: 32640829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of integrase inhibitor resistance mutations in Austrian patients recently diagnosed with HIV from 2008 to 2013.
    Zoufaly A; Kraft C; Schmidbauer C; Puchhammer-Stoeckl E
    Infection; 2017 Apr; 45(2):165-170. PubMed ID: 27530391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance-Associated Mutations and Polymorphisms among Integrase Inhibitor-Naïve HIV-1 Patients in Kuwait.
    Chehadeh W; Albaksami O; John SE; Al-Nakib W
    Intervirology; 2017; 60(4):131-137. PubMed ID: 29212076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencing.
    Nguyen T; Fofana DB; Lê MP; Charpentier C; Peytavin G; Wirden M; Lambert-Niclot S; Desire N; Grude M; Morand-Joubert L; Flandre P; Katlama C; Descamps D; Calvez V; Todesco E; Marcelin AG
    J Antimicrob Chemother; 2018 Sep; 73(9):2485-2492. PubMed ID: 29873733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of integrase strand transfer inhibitors for the treatment of human immunodeficiency virus infection.
    Park TE; Mohamed A; Kalabalik J; Sharma R
    Expert Rev Anti Infect Ther; 2015; 13(10):1195-212. PubMed ID: 26293294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of HIV integrase resistance mutations.
    Quashie PK; Mesplède T; Wainberg MA
    Curr Opin Infect Dis; 2013 Feb; 26(1):43-9. PubMed ID: 23242340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice.
    Alteri C; Scutari R; Bertoli A; Armenia D; Gori C; Fabbri G; Mastroianni CM; Cerva C; Cristaudo A; Vicenti I; Bruzzone B; Zazzi M; Andreoni M; Antinori A; Svicher V; Ceccherini-Silberstein F; Perno CF; Santoro MM
    Virus Genes; 2019 Jun; 55(3):290-297. PubMed ID: 30796743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa.
    Inzaule SC; Hamers RL; Noguera-Julian M; Casadellà M; Parera M; Rinke de Wit TF; Paredes R
    J Antimicrob Chemother; 2018 May; 73(5):1167-1172. PubMed ID: 29462322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitors.
    Low A; Prada N; Topper M; Vaida F; Castor D; Mohri H; Hazuda D; Muesing M; Markowitz M
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4275-82. PubMed ID: 19651917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short Communication: Trends in Transmitted Drug Resistance in Treatment-Naive HIV Patients in Korea.
    Jung EJ; Lee SH; Lee S; Lee JE; Lee SO; Park S; Kim HH; Kang JS; Woo HJ
    AIDS Res Hum Retroviruses; 2020 Nov; 36(11):905-909. PubMed ID: 32791842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study.
    Scherrer AU; Yang WL; Kouyos RD; Böni J; Yerly S; Klimkait T; Aubert V; Cavassini M; Battegay M; Hauser C; Calmy A; Schmid P; Bernasconi E; Günthard HF;
    J Infect Dis; 2016 Aug; 214(3):399-402. PubMed ID: 27130429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and structural analysis of HIV-1 integrase conservation.
    Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
    AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping.
    Casadellà M; Santos JR; Noguera-Julian M; Micán-Rivera R; Domingo P; Antela A; Portilla J; Sanz J; Montero-Alonso M; Navarro J; Masiá M; Valcarce-Pardeiro N; Ocampo A; Pérez-Martínez L; Pasquau J; Vivancos MJ; Imaz A; Carmona-Oyaga P; Muñoz-Medina L; Villar-García J; Barrufet P; Paredes R;
    J Antimicrob Chemother; 2020 Dec; 75(12):3517-3524. PubMed ID: 32929472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of integrase strand transfer inhibitors in HIV-infected treatment-experienced individuals across Europe.
    Rossetti B; Fabbiani M; Di Carlo D; Incardona F; Abecasis A; Gomes P; Geretti AM; Seguin-Devaux C; Garcia F; Kaiser R; Modica S; Shallvari A; Sönnerborg A; Zazzi M;
    HIV Med; 2022 Aug; 23(7):774-789. PubMed ID: 35199909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virological response to integrase strand transfer inhibitor-based antiretroviral combinations in HIV-1 group O-infected patients.
    Alessandri-Gradt E; Unal G; Leoz M; Plantier JC;
    AIDS; 2019 Jul; 33(8):1327-1333. PubMed ID: 30950879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practice.
    Alvarez M; Casas P; de Salazar A; Chueca N; Guerrero-Beltran C; Rodríguez C; Imaz A; Espinosa N; García-Bujalance S; Pérez-Elías MJ; García-Alvarez M; Iribarren JA; Santos J; Dalmau D; Aguilera A; Vinuesa D; Gutiérrez F; Piérola B; Molina JM; Peraire J; Portilla I; Gómez-Sirvent JL; Olalla J; Galera C; Blanco JR; Riera M; García-Fraile L; Navarro G; Curran A; Poveda E; García F;
    J Antimicrob Chemother; 2019 Jun; 74(6):1693-1700. PubMed ID: 30838386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors.
    Andreis S; Basso M; Scaggiante R; Cruciani M; Ferretto R; Manfrin V; Panese S; Rossi MC; Francavilla E; Boldrin C; Alvarez M; Dal Bello F; Mengoli C; Turriziani O; Sarmati L; Antonelli G; Andreoni M; Palù G; Parisi SG
    J Glob Antimicrob Resist; 2017 Sep; 10():106-112. PubMed ID: 28732792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.